12:00 AM
 | 
Feb 18, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Innovus, Prospector Capital Partners II LLC sales and marketing update

Innovus signed a binding term sheet to acquire nine prescription products approved in the U.S. from Prospector Capital. The products include Zytopic triamcinolone...

Read the full 95 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >